In this study we evaluated and compared the diagnostic performance of two third generation anti-CCP assays for RA; one that measures IgG anti-CCP antibodies only (CCP3) and one that non-discriminately detects both IgG and IgA anti-CCP antibodies (CCP3.1). This evidence concerns the gene CD79A and rheumatoid arthritis.